U.S. Banks Stock News

NasdaqGS:SIGI
NasdaqGS:SIGIInsurance

Is It Time To Reassess Selective Insurance Group (SIGI) After Recent Share Price Recovery?

Wondering whether Selective Insurance Group at around US$80.90 is starting to look interesting on value, or still has more risk than reward baked into the price. The stock is up 2.1% over the last week and 5.9% over the last month, although year to date it shows a 3.1% decline and the 1 year return sits at a 6.5% loss, with a 3 year return of 11.4% loss and a 5 year return of 14.4% gain. Recent coverage has focused on the share price performance and how it compares with the wider insurance...
NYSE:LH
NYSE:LHHealthcare

Is It Time To Reassess Labcorp (LH) After Its Recent Share Price Strength?

Wondering if Labcorp Holdings at around US$268.87 is still good value or starting to look fully priced, especially after a strong run? This article breaks that question down in plain terms. The stock has recently posted a 6.8% return year to date and 20.2% over the last year, with shorter term moves of 1.9% over 30 days and a slight 0.1% decline over 7 days that may have caught your attention. Recent news coverage has focused on Labcorp's position within the broader healthcare sector,...
NYSE:LPX
NYSE:LPXForestry

A Look At Louisiana-Pacific (LPX) Valuation As Recent Returns Turn Negative

Louisiana-Pacific (LPX) shares recently closed at $75.23. The total return over the past 3 months showed an 18.2% decline, and the year-to-date return was 8% lower for investors tracking performance. See our latest analysis for Louisiana-Pacific. Recent share price action has been choppy, with a 7.6% 7 day share price return sitting against a 90 day share price return decline of 18.2% and a weaker 1 year total shareholder return of 11.1%. If Louisiana-Pacific has you reassessing where to find...
NYSE:CXW
NYSE:CXWCommercial Services

CoreCivic (CXW) Valuation Check After Recent Trading Performance And Mixed Earnings Signals

CoreCivic Stock Moves After Recent Trading Performance CoreCivic (CXW) has drawn fresh attention after a recent move that leaves the stock at $19.95, with a roughly 10% gain over the past month and a small decline over the past year. See our latest analysis for CoreCivic. That recent 9.6% 1 month share price return sits alongside a 4.9% year to date share price return and a 3 year total shareholder return of about 120%, suggesting momentum has been built over time despite a weaker 1 year...
NYSE:JNJ
NYSE:JNJPharmaceuticals

One Off Gain Driven Margin Surge Tests Bullish Johnson & Johnson (JNJ) Narratives

Johnson & Johnson (JNJ) has opened Q1 2026 with investors focused on how its recent run of earnings ties back to underlying profitability, after reporting Q4 2025 revenue of US$24.6 billion and basic EPS of US$2.10 alongside trailing twelve month EPS of US$11.13 and revenue of US$94.2 billion. Over the last few quarters the company has seen revenue range from US$21.9 billion in Q1 2025 to US$24.6 billion in Q4 2025, while quarterly basic EPS has moved between US$1.41 in Q4 2024 and US$4.57 in...
NYSE:CAH
NYSE:CAHHealthcare

Cardinal Health Report Highlights Community Therapies And Raises New Investor Questions

Cardinal Health released its 2026 Advanced Therapies Report, focusing on how advanced treatments are shifting toward community-based care. The report outlines how providers are rethinking care delivery models to widen patient access outside traditional hospital settings. Findings add new detail to Cardinal Health's role in advanced therapies beyond its previously covered radiopharmaceutical expansions. For investors watching Cardinal Health (NYSE:CAH), the new report lands at a time when...
NasdaqGS:REPL
NasdaqGS:REPLBiotechs

Why Replimune Group (REPL) Is Down 75.0% After FDA Rejects RP1 Melanoma Application And What's Next

Replimune Group, Inc. recently received a complete response letter from the FDA rejecting its Biologics License Application for RP1 plus nivolumab in advanced melanoma, despite earlier breakthrough therapy designation and priority review based on the IGNYTE trial data set. The company is publicly challenging what it calls inconsistent FDA processes and shifting review teams, highlighting broader tensions around accelerated approvals for oncology drugs. Next, we’ll examine how the FDA’s...
NYSE:LNN
NYSE:LNNMachinery

A Look At Lindsay (LNN) Valuation After Weaker Second Quarter Sales And Earnings

Earnings slide puts Lindsay (LNN) under closer investor scrutiny Lindsay (LNN) has moved into focus after reporting a year over year decline in both sales and net income for its second quarter and first half of fiscal 2026. The company posted second quarter sales of US$157.72 million and net income of US$12.05 million, compared with US$187.06 million and US$26.58 million a year earlier. This has prompted investors to reassess recent share performance. See our latest analysis for...
OTCPK:DIDI.Y
OTCPK:DIDI.YTransportation

DiDi’s New L4 Robotaxi Rollout Could Be A Game Changer For DiDi Global (DIDI.Y)

DiDi Global’s autonomous driving unit recently unveiled a next‑generation Robotaxi co-developed with GAC Aion, featuring upgraded L4-level self-driving capabilities, an enhanced smart cockpit, and the start of on-road testing. CEO Zhang Bo’s emphasis on a hybrid mobility network that blends human-driven and autonomous vehicles underlines DiDi’s pragmatic approach to deploying AI in complex real-world traffic conditions. We will now examine how DiDi’s focus on a hybrid human-autonomous...
NYSE:KMI
NYSE:KMIOil and Gas

Is Kinder Morgan (KMI) Pricing Reflecting Its Strong Multi‑Year Share Price Performance?

Before getting into the numbers, it helps to ask a simple question: at around US$31.65 per share, are you paying a fair price for Kinder Morgan or leaving value on the table? Recent returns have been mixed, with the share price down around 5.0% over the last week and 5.2% over the last month, while still showing a 14.2% gain year to date and 21.3% over the past year. Short-term moves like these often sit against a longer backdrop. In Kinder Morgan's case, the 3 year return is 109.7% and the 5...
NasdaqGS:TTWO
NasdaqGS:TTWOEntertainment

GTA VI Online Refresh Puts Take-Two’s Recurring Revenue Model In Focus

Take-Two Interactive Software (NasdaqGS:TTWO) is preparing a new iteration of GTA Online alongside the future launch of Grand Theft Auto VI. The refreshed GTA Online is expected to continue using in-game purchases that have supported recurring, high-margin revenue for the company over the past decade. Investors are watching how this updated online platform could influence the mix and stability of Take-Two's digital revenue profile. For anyone following NasdaqGS:TTWO, the focus now is less...
NasdaqGS:IDCC
NasdaqGS:IDCCSoftware

Is It Too Late To Consider InterDigital (IDCC) After A 75% One Year Surge?

If you are wondering whether InterDigital's share price still reflects its underlying value after a strong run, this breakdown is aimed at helping you frame that question clearly. The stock recently closed at US$352.32, with returns of 11.7% over 7 days, 8.0% year to date and 75.2% over 1 year, while the 3 year and 5 year returns are both very large. Recent headlines around InterDigital have focused on its role in software and licensing, along with ongoing interest in how its technology...
NYSE:ACI
NYSE:ACIConsumer Retailing

Albertsons Companies (ACI) Q3 Earnings Highlight Thin 1.1% Net Margin Pressure

Albertsons Companies (ACI) has put another quarter on the board, with Q3 FY 2026 revenue of US$19.1b, basic EPS of US$0.55 and net income of US$293.3m, plus same store sales growth of 2.4%. Over the past few quarters, the company has reported revenue of US$18.8b in Q2 FY 2026 and US$18.8b in Q3 FY 2025, rising to US$19.1b in the latest quarter. Basic EPS over the same periods was US$0.30 and US$0.69 respectively, before reaching US$0.55 in Q3 FY 2026. These figures set the scene for investors...
NYSEAM:REPX
NYSEAM:REPXOil and Gas

Are Riley Exploration Permian’s New Mexico and ERCOT Plans Reframing Its Infrastructure Story (REPX)?

Riley Exploration Permian, Inc. recently presented at the Water Tower Research Insights Conference on April 14, 2026, offering investors and analysts fresh commentary on its operations and outlook. This conference appearance gives the company a platform to explain its infrastructure plans in New Mexico and ERCOT power initiatives directly to the market. We’ll now consider how this conference presentation, and any additional detail on New Mexico infrastructure and ERCOT power projects, might...
NasdaqCM:SMPL
NasdaqCM:SMPLFood

Simply Good Foods Probed On Disclosures After Guidance Cut And Impairment

The Schall Law Firm has opened a securities law investigation into Simply Good Foods (NasdaqCM:SMPL). The probe centers on whether the company misled investors or omitted material information before cutting guidance and recording an impairment. This follows earlier attention on the company’s weak earnings, impaired outlook, and share price decline. Simply Good Foods, known for its branded nutritional snacks and meal replacement products, now faces legal scrutiny in addition to its recent...
NasdaqCM:BCAL
NasdaqCM:BCALBanks

Undervalued Small Caps With Insider Buying In April 2026

Over the last 7 days, the United States market has risen by 4.4%, contributing to a remarkable 32% increase over the past year, with earnings forecasted to grow by 16% annually. In this thriving environment, identifying small-cap stocks that are potentially undervalued and exhibit insider buying can offer intriguing opportunities for investors seeking to capitalize on current market conditions.
NYSE:TOST
NYSE:TOSTDiversified Financial

April 2026's Estimated Undervalued Stocks For Savvy Investors

Over the last week, the United States market has seen a 4.4% increase, contributing to an impressive 32% rise over the past year, with earnings expected to grow by 16% annually. In such a thriving environment, identifying stocks that are potentially undervalued can offer investors opportunities for growth by focusing on companies with strong fundamentals and attractive valuations relative to their peers.
NYSE:LOAR
NYSE:LOARAerospace & Defense

3 Growth Stocks With High Insider Ownership And 43% Earnings Growth

The United States market has experienced a notable upswing, climbing 4.4% in the last week and showing a robust 32% increase over the past year, with earnings forecasted to grow by 16% annually. In this thriving environment, identifying growth companies with high insider ownership can be particularly appealing as they often signal confidence from those closest to the business and potential alignment with shareholder interests.
NYSE:SES
NYSE:SESElectrical

Discovering Whitehawk Therapeutics Among 3 Promising Penny Stocks

The market has climbed 4.4% in the last 7 days and is up 32% over the past year, with earnings forecasted to grow by 16% annually. Though the term 'penny stock' might sound like a relic of past trading days, these smaller or newer companies can still offer significant opportunities when they have solid financials. We've identified three penny stocks that combine balance sheet strength with potential for outsized gains, giving investors a chance to uncover hidden value in quality companies.
NasdaqGS:XNET
NasdaqGS:XNETSoftware

Undiscovered Gems In The US Market For April 2026

Over the last 7 days, the United States market has risen by 4.4%, contributing to a remarkable 32% increase over the past year, with earnings expected to grow by 16% annually. In this thriving environment, identifying stocks that combine solid fundamentals with growth potential can uncover promising opportunities for investors seeking undiscovered gems.
NYSE:MDT
NYSE:MDTMedical Equipment

3 Top Dividend Stocks To Consider With At Least 3% Yield

Over the last 7 days, the United States market has risen by 4.4%, contributing to a remarkable 32% increase over the past year, with earnings forecasted to grow by 16% annually. In this robust market environment, dividend stocks with yields of at least 3% can offer investors a combination of income and potential capital appreciation, making them an attractive option for those seeking steady returns amidst growth opportunities.
NYSE:FN
NYSE:FNElectronic

Is Fabrinet (FN) Still Attractive After A 262% One Year Share Price Surge

If you are trying to figure out whether Fabrinet's share price reflects its real worth, this is the place to start. The stock last closed at US$681.68, with returns of 22.2% over 7 days, 35.8% over 30 days, 42.2% year to date, 261.6% over 1 year, 603.2% over 3 years, and a very large gain over 5 years. Recent coverage of Fabrinet has focused on its role in high performance optical and electronic manufacturing, as customers look for partners that can handle complex, high value hardware. This...